galantamine has been researched along with Endotoxemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Addorisio, ME; Al-Abed, Y; Al-Onaizi, MA; Chavan, SS; Gros, R; Lehner, KR; Levine, Y; Metz, CN; Nathanson, NM; Olofsson, PS; Pavlov, VA; Prado, MAM; Prado, VF; Roy, A; Silverman, HA; Tracey, KJ | 1 |
| Al-Abed, Y; Chavan, S; Ochani, K; Ochani, M; Parrish, WR; Pavlov, VA; Puerta, M; Rosas-Ballina, M; Tracey, KJ | 1 |
2 other study(ies) available for galantamine and Endotoxemia
| Article | Year |
|---|---|
Forebrain Cholinergic Signaling Regulates Innate Immune Responses and Inflammation.
Topics: Acetylcholine; Animals; Anti-Inflammatory Agents; Cholinergic Agonists; Cholinesterase Inhibitors; Cytokines; Endotoxemia; Galantamine; Immunity, Innate; Inflammation; Male; Mice, Inbred C57BL; Mice, Transgenic; Prosencephalon; Quinolines; Receptor, Muscarinic M1; Vesicular Acetylcholine Transport Proteins | 2019 |
Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.
Topics: Acetylcholinesterase; Alkaloids; alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Atropine Derivatives; Brain; Cholinesterase Inhibitors; Cytokines; Endotoxemia; Enzyme-Linked Immunosorbent Assay; Female; Galantamine; Injections, Intraperitoneal; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Parasympatholytics; Receptors, Nicotinic; Sesquiterpenes; Tumor Necrosis Factor-alpha; Vagotomy | 2009 |